DCN Dx Announces "Early Bird" Registration Rates for 2025 Advanced Lateral Flow Conference

Early registration includes discounted rates for industry professionals, academics, and non-profits until April 30

LA JOLLA, Calif., March 6, 2025 /PRNewswire/ -- DCN Dx, a global leader in the development, manufacturing, and commercialization of point-of-use diagnostic tests, has announced that early bird registration is now open for the 2025 Advanced Lateral Flow Conference (ALFC). The two-day event will take place October 14–15, 2025, at the Hilton La Jolla Torrey Pines in La Jolla, Calif.

Early bird rates, available until April 30, 2025, offer discounts on:

• Industry Professionals (Live Attendance): $2,250 per attendee (10% discount)
• Academic and Non-Profit Organizations (Live Attendance): $1,750 per attendee (12.5% discount)

Additional pricing options include these regular rates:

• Students (Live Attendance): $400 per attendee
• Virtual Attendance: $1,250 per attendee

The ALFC is the leading global event for lateral flow diagnostic developers, manufacturers, and those driving their commercial success. The 2025 program will feature expert-led sessions on the current state of lateral flow immunoassays, emerging applications for point-of-care technologies, future trends in rapid diagnostic testing, and more.

Participants can expect practical insights into complex problem-solving in diagnostics, along with numerous networking opportunities through organized evening events, shared meals, and dedicated breaks. An exhibition hall and poster sessions will highlight the latest advancements in rapid diagnostics, culminating in an awards ceremony celebrating innovation and excellence within the industry.

"We're thrilled to welcome lateral flow industry leaders, researchers, and innovators to ALFC 2025," said Mitzi Rettinger, chair of the ALFC 2025 organizing committee. "The ALFC is an invaluable resource for staying at the forefront of this dynamic field."

DCN Dx encourages attendees to secure their spots early and take advantage of early bird pricing. To register or learn more, visit ALFC2025.com.

About the Advanced Lateral Flow Conference

The Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is the leading global event for lateral flow diagnostic developers, manufacturers, and those driving their commercial success. This annual conference delivers cutting-edge insights through expert-led sessions and provides a platform for researchers and developers to exchange ideas and innovations. Attendees gain practical insights to advance their businesses, deepen their knowledge of rapid diagnostics, and connect with leading minds shaping the future of point-of-care testing. To learn more about ALFC, visit alfc2025.com.

About DCN Dx

DCN Dx, based in Carlsbad, California, specializes in lateral flow diagnostics development and manufacturing, and IVD regulatory consulting and clinical research. DCN Dx's multidisciplinary CDMO specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays. Their clinical research services group specializes in the planning, execution, and oversight of IVD clinical trials, inclusive of clinical operations, data management, and biostatistics, and regulatory services.

To learn more about how we can support your diagnostic needs, visit dcndx.com.

MEDIA CONTACT
Mitzi Rettinger
Chief Revenue Officer, DCN Dx
Main: (760) 804-3886
Mobile: (512) 431-5836
[email protected] 

SOURCE DCN Dx